Comparing Maximus with Hone Health begins with deciding what the displayed price buys. Maximus’s oral page prices a particular compounded treatment offering. Hone describes membership levels and medication costs separately. Comparing the lowest visible numbers would hide that difference.
We checked the public pages on September 23, 2026. This guide focuses on the questions needed for a fair quote and clinical conversation. We have not assessed either service through patient care or found evidence that establishes one as the better medical choice for every reader.
KEEP IN MIND
The useful bits.
- Hone membership and medication charges are separate.
- Maximus’s compounded oral product is distinct from approved oral brands.
- Compare complete care costs after introductory offers expire.
Separate membership from medicine
Maximus’s oral plan displays ordinary monthly rates of $249.99, $199.99, and $149.99 for one-, three-, and six-month options. A limited six-month promotion reduces the first month to $74.99 before the continuing rate. Ask which payment structure and prescription apply to you; the product page notes potential variation.
Hone lists Basic membership at $25 monthly and Premium at $155 monthly, with medication extra. Its $65 starting assessment is another distinct expense. Basic should not be read as a complete $25 TRT program: consultation access and other services depend on the membership and purchase. Request a complete treatment estimate rather than adding together guesses.
Sources: Maximus: compounded oral testosterone, plan prices, and laboratory requirements · Hone Health: Basic and Premium memberships and starting assessment
A route preference is not a diagnosis
Wanting to avoid needles is reasonable, but it does not determine whether testosterone treatment is indicated. A clinician needs symptoms, reliable laboratory results, medical history, and an evaluation of possible causes. Age-related tiredness alone does not settle the diagnosis or identify the most suitable medicine.
Maximus lists several treatment categories beyond its oral preparation. Do not assume the first product shown in an advertisement is the one a clinician will recommend. Our testing guide for men over 50 explains the assessment questions to address before comparing convenience or committing to an extended payment plan.
Sources: Endocrine Society: testosterone therapy clinical guidance · Maximus: testosterone treatment options
Compounded oral testosterone needs product-specific evidence
Maximus identifies its oral product as compounded native testosterone. It should not inherit the approval status or dosing instructions of Kyzatrex, which contains testosterone undecanoate. Likewise, Hone’s membership price does not identify the product an individual member will be prescribed.
Ask both clinicians to specify the exact medicine, dispensing pharmacy, approval status, and expected monitoring. If a compounded medicine is recommended, discuss the reason and available alternatives. FDA does not approve compounded preparations. Our Maximus review examines the oral offer’s evidence boundaries and the difference between company marketing and independently verified outcomes.
Sources: Maximus: compounded oral testosterone, plan prices, and laboratory requirements · FDA: understanding the risks of compounded drugs · DailyMed: Kyzatrex oral testosterone undecanoate prescribing information
Ask how the testing relationship works
Maximus permits review of certain outside results from the preceding six months, subject to required markers and clinical acceptance. Hone’s assessment and membership structure should be read for its own testing and consultation terms. An uploaded report is not a guarantee that a clinician can proceed without more information.
Request a schedule showing the first clinical review, follow-up laboratory work, and who contacts you if results are abnormal. Ask whether a repeat test or an additional visit changes the bill. These answers tell you more about practical continuity than the number of features listed on a membership comparison card.
Sources: Maximus: compounded oral testosterone, plan prices, and laboratory requirements · Hone Health: Basic and Premium memberships and starting assessment · Endocrine Society: testosterone therapy clinical guidance
Make the longer-term commitment explicit
For both services, find out what happens financially if the clinician changes the route, pauses treatment, or recommends stopping. A limited discount should be shown separately from the continuing cost. Add medication and any separately charged services to the cost worksheet before comparing equal periods.
The Hone review and oral treatment guide provide more detail. Discuss blood pressure, fertility goals, and other monitoring needs regardless of route. Neither a premium membership nor a needle-free product removes the need for a clinician to explain risks and follow changes over time.
Sources: Maximus: compounded oral testosterone, plan prices, and laboratory requirements · Hone Health: Basic and Premium memberships and starting assessment · FDA: 2025 testosterone labeling and blood pressure changes
Sources you can check
Provider pages describe commercial offers. Medical references provide context. Checked September 23, 2026; prices and availability can change.
- Maximus: compounded oral testosterone, plan prices, and laboratory requirements
- Hone Health: Basic and Premium memberships and starting assessment
- Endocrine Society: testosterone therapy clinical guidance
- Maximus: testosterone treatment options
- FDA: understanding the risks of compounded drugs
- DailyMed: Kyzatrex oral testosterone undecanoate prescribing information
- FDA: 2025 testosterone labeling and blood pressure changes
Educational information for adults, not a diagnosis or treatment plan. Discuss symptoms and treatment decisions with a licensed clinician. Do not change a prescription based on this article.